A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Public ClinicalTrials.gov record NCT06722235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants With Chronic Primary Immune Thrombocytopenia
Study identification
- NCT ID
- NCT06722235
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 171 participants
Conditions and interventions
Conditions
Interventions
- Mezagitamab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2025
- Primary completion
- Dec 27, 2027
- Completion
- Dec 27, 2027
- Last update posted
- May 7, 2026
2025 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USC Norris Comprehensive Cancer Center - Keck Medicine of USC | Los Angeles | California | 90033 | Recruiting |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | Withdrawn |
| Georgetown University Medical Center - Lombardi Comprehensive Cancer Center | Washington D.C. | District of Columbia | 20007 | Recruiting |
| Emory University | Atlanta | Georgia | 30308 | Recruiting |
| The University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| University Of Louisville Brown Cancer Center | Louisville | Kentucky | 40202 | Recruiting |
| American Oncology Partners of Maryland, PA | Bethesda | Maryland | 20817 | Not yet recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01655 | Recruiting |
| Duke University Hospital | Durham | North Carolina | 27710 | Recruiting |
| East Carolina University | Greenville | North Carolina | 27837 | Recruiting |
| Oregon Health & Science University | Portland | Oregon | 97239 | Recruiting |
| Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Lewis Katz School of Medicine at Temple University | Philadelphia | Pennsylvania | 19140 | Recruiting |
| Baylor College of Medicine | Houston | Texas | 77030 | Recruiting |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | Recruiting |
| University of Washingto | Seattle | Washington | 98109 | Not yet recruiting |
| Versiti Wisconsin, Inc | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06722235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06722235 live on ClinicalTrials.gov.